http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-190541-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f51a0d2b763f7fd1280da4cd8f1fc53f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d718e6e6a33871f6483770a05d8b385b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521bce676d4169347c1a6368f320f674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfa0c5521bb5900639c564447537164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6fe3cc770dcef32728751f3d6408e5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48aad0612c6a18223bdaee5fc8d80656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a1c367bdbe0f6db22060cf7e3aab9b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4661ef66c30221cc780452962bba3bfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2389e5723a3e24fed0a5b86f9d1e431c
publicationDate 2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-190541-A
titleOfInvention Aminopyridyloxypyrazole compounds
abstract The present invention relates to novel aminopyridyloxypyrazole compounds that inhibit the activity of transforming growth factor beta receptor 1 (TGF?Rl ), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, preferably colon cancer, melanoma, hepatocellular carcinoma, renal cancer, glioblastoma, pancreatic cancer, myelodysplastic syndrome, lung cancer, and gastric cancer, and/or fibrosis, preferably liver fibrosis and chronic kidney disease .
priorityDate 2014-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29591
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21812
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7046
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID481628
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121249287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282382
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID560578
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432678107

Total number of triples: 44.